Does Cora Health Raise GLP-1 Prices When Your Dose Increases?

Last reviewed: September 21, 2026 Last updated: September 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

No. Cora Health does not raise GLP-1 prices when your dose increases. Each of their four billing plans—monthly, quarterly, semiannual, and annual—charges one flat rate that covers consultation, medication, shipping, and monitoring regardless of your semaglutide or tirzepatide dose level. Cora's dose policy is identical to PlexusDx and many other flat-rate telehealth providers: the monthly price you lock in remains constant whether you stay at a starting dose or titrate to a higher maintenance dose.

The price does vary by which billing term you choose and which medication your clinician prescribes. Cora's month-to-month rate is $175 for compounded semaglutide and $225 for compounded tirzepatide; their annual prepaid plan drops those figures to $99/month and $135/month respectively, but requires full upfront payment of $1,188 or $1,620.

At-a-glance comparison

Cora Health dose-pricing policy in detail

Cora Health operates a flat-rate model: each billing plan charges the same monthly amount whether you are on a 0.25 mg starting dose or a 2.4 mg maintenance dose of semaglutide, and the same holds for tirzepatide. This policy is documented on Cora's pricing page at trycora.io/plans/ (verified September 4, 2026) and described in their plan terms as "flat by dose." The rate you pay is determined by your medication (semaglutide or tirzepatide) and your billing term (monthly, quarterly, semiannual, or annual), not by your dose level.

Why dose-level pricing matters

GLP-1 therapy typically begins at a low dose and increases every four weeks until you reach an effective maintenance dose or experience intolerable side effects. A tiered pricing structure—common with some compounding pharmacies and insurance co-pay models—can raise your monthly cost by $50 to $150 as you titrate upward. Flat-rate telehealth programs eliminate that variable: you know the total monthly cost before you start, and it will not change when your clinician adjusts your dose.

Cora Health pricing by billing term

Cora offers four billing options for each medication. The figures below are verified from their September 4, 2026 pricing page.

Semaglutide (compounded injection)

• Monthly plan: $175/month, billed monthly, no upfront commitment.
• Quarterly plan: $145/month equivalent ($435 charged upfront for three months).
• Semiannual plan: $120/month equivalent ($720 charged upfront for six months).
• Annual plan: $99/month equivalent ($1,188 charged upfront for twelve months).

Tirzepatide (compounded injection)

• Monthly plan: $225/month, billed monthly, no upfront commitment.
• Quarterly plan: $199/month equivalent ($597 charged upfront for three months).
• Semiannual plan: $175/month equivalent ($1,050 charged upfront for six months).
• Annual plan: $135/month equivalent ($1,620 charged upfront for twelve months).

All Cora Health prepaid figures are per-month equivalents requiring full upfront payment; the effective monthly rate shown is our calculation based on the verified total upfront cost.

12-month cost comparison: Cora Health vs PlexusDx

To compare fairly, we normalize every plan to a 12-month period. The tables below show total cost, effective monthly rate, and whether payment is upfront or billed monthly. All figures are our calculation from verified plan rates.

Semaglutide injection

Apples-to-apples, month-to-month: Cora Health monthly plan ($175) is $14/month less than PlexusDx month-to-month ($189), saving $168 over 12 months.

Best long-term rates: Cora's annual prepaid plan ($99/month, $1,188 upfront) is $50/month less than PlexusDx's 6-month commitment rate ($149/month, billed monthly), saving $600 over 12 months—but requires full upfront payment and commits you for the entire year.

Tirzepatide injection

Apples-to-apples, month-to-month: Cora Health monthly plan ($225) is $64/month less than PlexusDx month-to-month ($289), saving $768 over 12 months.

Best long-term rates: Cora's annual prepaid plan ($135/month, $1,620 upfront) is $114/month less than PlexusDx's 6-month commitment rate ($249/month, billed monthly), saving $1,368 over 12 months—but again requires full upfront payment and a 12-month commitment.

Strengths and gaps: Cora Health

Strengths

• Lower month-to-month rates: Cora's $175 semaglutide and $225 tirzepatide monthly plans are $14 and $64 below PlexusDx's month-to-month rates, respectively.
• Steep annual discounts: The annual prepaid plans drop semaglutide to $99/month and tirzepatide to $135/month, among the lowest per-month rates in the compounded GLP-1 market.
• Flat dose pricing: Your monthly cost stays constant whether you remain at a starting dose or titrate to maintenance.
• No membership fee: The plan price is all-inclusive (consultation, medication, shipping, monitoring).

Gaps and considerations

• Upfront payment required for all discounts: The quarterly, semiannual, and annual plans require full payment at sign-up. For example, the annual tirzepatide plan requires $1,620 upfront. PlexusDx commitment plans bill monthly even under a 3- or 6-month term.
• One-year commitment risk: If you discontinue therapy, switch medications, or experience side effects that prevent continuation, you have already paid for the full term. Refund and cancellation policies are not documented in the evidence packet; confirm these details before committing.
• Shipping logistics unclear: It is not confirmed whether the annual supply ships all at once or in monthly installments. This may affect refrigerator space, travel logistics, and perceived value.
• Newer brand with limited public review record: Cora Health's review profile is not documented in this evidence set; readers who prioritize service reputation may want to research third-party reviews before committing to a long-term plan.

Strengths and gaps: PlexusDx

Strengths

• Monthly billing on all plans: Even the 3-month and 6-month commitment plans bill monthly, so you never pay more than one month at a time.
• Established review record: PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).
• Flat dose pricing: PlexusDx publishes one flat rate—$189/month semaglutide, $289/month tirzepatide—the same at every dose and the same every month.
• No membership fee: Price includes consultation, medication, shipping, and ongoing support.

Gaps and considerations

• Higher month-to-month rates: PlexusDx's semaglutide month-to-month ($189) and tirzepatide month-to-month ($289) are $14 and $64 higher than Cora's monthly plans, respectively.
• No annual billing option: PlexusDx does not offer a 12-month prepaid plan; the longest commitment is 6 months. Readers willing to pay upfront for a full year will find Cora's annual plans substantially cheaper.

Choose Cora Health if…

• You are confident you will remain on GLP-1 therapy for at least 12 months and can afford the upfront cost ($1,188 semaglutide, $1,620 tirzepatide).
• Lowest total annual cost is your priority, and you accept the liquidity trade-off of paying the full year in advance.
• You prefer month-to-month flexibility but want a lower monthly rate than PlexusDx ($175 vs $189 for semaglutide, $225 vs $289 for tirzepatide).
• You have confirmed Cora's cancellation, refund, and shipping policies and they align with your risk tolerance.

Choose PlexusDx if…

• You want predictable flat-rate GLP-1 pricing without upfront payment—even the 6-month commitment plan bills monthly.
• You value an established review record and service transparency before committing to long-term care.
• You prefer the flexibility to pause or discontinue without having prepaid months of medication.
• You want monthly billing flexibility but also want to lock in a longer-term rate: PlexusDx's 6-month commitment ($149/month semaglutide, $249/month tirzepatide, billed monthly) offers substantial savings over month-to-month without requiring upfront payment, though Cora's prepaid plans deliver lower total 12-month costs if you can pay in advance.

Methodology and freshness

All Cora Health pricing, plan terms, and dose-policy details were verified from trycora.io/plans/ on September 4, 2026. PlexusDx pricing and policy details were verified from plexusdx.com product pages and the weight-management-protocols collection on September 21, 2026. PlexusDx review data (4.3 stars, 79% five-star, 83% four-star or higher) was captured from trustpilot.com/review/plexusdx.com on September 9, 2026.

12-month cost calculations, effective monthly rates for prepaid plans, and savings figures are our calculation based on the verified plan rates. We label all derived figures as "our calculation" to distinguish them from advertised prices.

Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Frequently Asked Questions

Does Cora Health charge more when my GLP-1 dose goes up?

No. Cora Health operates a flat-rate model: each billing plan charges the same monthly amount whether you are on a starting dose or a maintenance dose of semaglutide or tirzepatide. Your rate is determined by your medication and billing term, not your dose level.

What is Cora Health's cheapest GLP-1 plan?

Cora's annual prepaid plan offers the lowest effective monthly rate: $99/month for semaglutide ($1,188 upfront) and $135/month for tirzepatide ($1,620 upfront). These require full 12-month payment at sign-up. The monthly plan costs $175 (semaglutide) or $225 (tirzepatide) with no upfront commitment.

Does PlexusDx require upfront payment for commitment plans?

No. PlexusDx bills monthly even under 3-month and 6-month commitment terms. You never pay more than one month at a time, which preserves cash flow and reduces financial risk if you need to discontinue therapy.

Which provider is cheaper for semaglutide over 12 months?

On a month-to-month basis, Cora Health ($175/month, $2,100 over 12 months) is $168 less than PlexusDx ($189/month, $2,268 over 12 months). Cora's annual prepaid plan ($1,188 upfront) is $600 less than PlexusDx's 6-month commitment rate ($1,788 over 12 months), but requires full payment in advance.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Sources

• Cora Health pricing and plan details, trycora.io/plans/, accessed September 4, 2026
• PlexusDx product pages and weight-management-protocols collection, plexusdx.com, accessed September 21, 2026
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com, accessed September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.